K65N (p.Lys65Asn) variant of ATL1 (Atlastin-1)

K65N (p.Lys65Asn) in ATL1 (Atlastin-1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

K65N (p.Lys65Asn) variant details